Clinical Trials · NCT01078753
Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 89
- Start date
- Jan 2010
- Locations
- 15 sites, Japan
- Primary endpoint
- Change in the Number of Wet Nights Between Baseline and Treatment Period II